Organization

Duarte, CA

29 abstracts

Abstract
Immuno-chemotherapy as single treatment modality for larynx preservation (ICoLP): Co-primary endpoints and safety results.
Org: The University of Texas MD Anderson Cancer Center, MD Anderson Cancer Center, University of Texas MD Anderson Cancer Center, Thoracic/Head and Neck Medical Oncology, Houston, TX,
Abstract
Effect of CBM588 in combination with cabozantinib plus nivolumab for patients (pts) with metastatic renal cell carcinoma (mRCC): A randomized clinical trial.
Org: City of Hope Comprehensive Cancer Center, CanSino Biologics, Flagstaff, Yale University School of Medicine, CTI BioPharma,
Abstract
Circulating kidney injury molecule-1 (KIM-1) biomarker analysis in IMmotion010: A randomized phase 3 study of adjuvant (adj) atezolizumab (atezo) vs placebo (pbo) in patients (pts) with renal cell carcinoma (RCC) at increased risk of recurrence after resection.
Org: Gustave Roussy Cancer Center, Université Paris Saclay, Paris, France, Royal Free London NHS Foundation Trust, UCL Division of Surgery and Interventional Science,
Abstract
Cabazitaxel with abiraterone versus abiraterone alone randomized trial for extensive disease following docetaxel: The CHAARTED2 trial of the ECOG-ACRIN Cancer Research Group (EA8153).
Org: University of Wisconsin Carbone Cancer Center, Madison, WI, Dana-Farber Cancer Institute, Boston, MA, University of Wisconsin,
Abstract
Geriatric assessment-directed supportive care intervention (GAIN-S)-implementation via telehealth in a lower-resourced community.
Org: City of Hope National Medical Center, Duarte, CA, CanSino Biologics, City of Hope National Comprehensive Cancer Center, City of Hope Comprehensive Cancer Center,
Abstract
Integration of a machine learning model-generated surgical risk score into the EHR and preoperative workflow.
Org: City of Hope National Medical Center, Duarte, CA, CanSino Biologics, City of Hope National Comprehensive Cancer Center,
Abstract
A randomized phase II study of gemcitabine and nab-paclitaxel compared with 5-fluorouracil, leucovorin, and liposomal irinotecan in older patients with treatment-naïve metastatic pancreatic cancer (GIANT): ECOG-ACRIN EA2186.
Org: Fox Chase Cancer Center, Dana-Farber Cancer Institute, Wake Forest University Department of General Internal Medicine, Stanford University School of Medicine, ThedaCare Regional Medical Center,
Abstract
Health-related quality of life (HRQOL) results from PRESTO (AFT-19), a phase 3 randomized trial of intensification of androgen blockade in patients with high-risk biochemically relapsed castration sensitive prostate cancer.
Org: University of Kansas Medical Center, Mayo Clinic, Mayo Clinic Cancer Center, Washington University in St. Louis, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute,
Abstract
Post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis following mismatched unrelated donor peripheral blood stem cell (PBSC) transplantation.
Org: City of Hope National Medical Center, CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Medical College of Wisconsin, Memorial Sloan Kettering Cancer Center,
Abstract
Characterization of cancer clinical trials in the community setting.
Org: Flatiron Health, San Francisco, CA, New York Oncology Hematology PC, Nykode Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA,
Abstract
Safety and efficacy of osimertinib plus consolidative stereotactic ablative radiation (SABR) in advanced EGFR mutant non-small cell lung cancer (NSCLC): Results from a multi-center phase II trial.
Org: UT Southwestern Medical Center, Dallas, City of Hope National Comprehensive Cancer Center, Duarte, CA, Memorial Sloan Kettering Cancer Center,
Abstract
A phase 1/2, open-label, multicenter, dose escalation and cohort expansion study of the safety and efficacy of anti-CD70 allogeneic CRISPR-Cas9–engineered T cells (CTX131) in adult patients with relapsed or refractory solid tumors.
Org: City of Hope Comprehensive Cancer Center, Duarte, CA, Washington University School of Medicine in St Louis, St. Louis, MO, Sarah Cannon Research Institute/Tennessee Oncology,
Abstract
Botensilimab plus balstilimab in microsatellite stable metastatic colorectal cancer: Assessing efficacy in non-liver metastatic sites.
Org: Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, Beth Israel Deaconess Medical Center, Boston, MA,
Abstract
Effect of P. gingivalis on osimertinib resistance in EGFR-mutant lung cancer.
Org: City of Hope National Medical Center, Duarte, CA, Weizmann Institute of Science, Rehovot, Israel, City of Hope Comprehensive Cancer Center Department of Medical Oncology and Therapeutics Research,
Abstract
Predictive biomarkers of benefit to axitinib plus avelumab in patients with recurrent/metastatic adenoid cystic carcinoma (R/M ACC).
Org: The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation Rsch, Houston, TX, Houston Methodist Hospital, Department of Pathology and Genomic Medicine, Txinno Bioscience, Cleveland Clinic Taussig Cancer Instititute, OHB Neonatology,
Abstract
Impact of synchronous (sync) vs metachronous (meta) metastasis at the presentation on survival in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with androgen receptor signaling inhibitors (ARSIs).
Org: Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT, UTC Therapeutics, Hunstman Cancer Institute at the University of Utah, City of Hope Comprehensive Cancer Center,
Abstract
Results of SOC-2082 phase 2 study using metronomic gemcitabine, doxorubicin and docetaxel plus nivolumab as second/third-line therapy for advanced sarcoma.
Org: Sarcoma Oncology Research Center, Santa Monica, CA, Santa Monica, CA, City of Hope Comprehensive Cancer Center, Duarte, CA, Aveni Foundation,
Abstract
The association of sociodemographic variables with smoking prevalence in patients enrolled on clinical trials.
Org: City of Hope National Comprehensive Cancer Center, Duarte, CA, CanSino Biologics, SWOG Statistics and Data Management Center, Seattle, WA, Seattle Gummy Company,
Abstract
Factors associated with response to neoadjuvant chemotherapy and immune checkpoint inhibition in triple-negative breast cancer.
Org: City of Hope Comprehensive Cancer Center, Duarte, CA, Cedars-Sinai Cancer Center, Los Angeles Medical Center,
Abstract
Artificial intelligence analysis of CCNG1 expression in tumors: A novel biomarker in development for anti-CCNG1 targeted therapy.
Org: Sarcoma Oncology Research Center, Santa Monica, CA, Santa Monica, CA, Dornsife College of Letters, University of Southern California, Los Angeles, CA, University of California Los Angeles,
Abstract
Updated efficacy and safety of entrectinib in patients (pts) with locally advanced/metastatic NTRK fusion-positive (fp) non-small cell lung cancer (NSCLC).
Org: Yonsei University College of Medicine, Seoul, Korea, Republic of (South), Taipei Medical University Hospital, Taipei City, Taiwan, City of Hope Comprehensive Cancer Center,
Abstract
Network-enabled rapid growth of a US-based remote asynchronous oncology subspecialist case review service.
Org: City of Hope National Medical Center, Duarte, CA, City of Hope Cancer Center, AccessHope, Los Angeles Medical Center,
Abstract
Immune checkpoint inhibitor effects on male reproduction.
Org: Harbor-UCLA Medical Center, Torrance, CanSino Biologics, The Lundquist Institute, City of Hope Comprehensive Cancer Center,
Abstract
Falls and hospitalization during chemotherapy in older women with early breast cancer.
Org: City of Hope National Medical Center, Duarte, CA, University of Nebraska Medical Center, Omaha NE, Neurocentria,
Abstract
Anthracycline-related cardiotoxicity among patients with lymphoma: Systematic review and meta-analysis.
Org: Mayo Clinic, Rochester Regional Health System, MN, Mayo Clinic-Rochester, City of Hope National Medical Center,